Hetzer R, Müller J H, Weng Y G, Loebe M, Wallukat G
Deutsches Herzzentrum, Berlin, Germany.
J Thorac Cardiovasc Surg. 2000 Nov;120(5):843-53. doi: 10.1067/mtc.2000.108931.
Cardiac recovery in end-stage idiopathic dilated cardiomyopathy recently occurred after temporary support with a left ventricular assist device. We report the case histories of patients who underwent removal of the device more than 4 years ago.
Since June 1994, 23 patients with end-stage idiopathic dilated cardiomyopathy who were supported by a left ventricular assist device or biventricular assist device for 1 to 26 months (mean, 6 months) underwent removal of the device after complete or extensive cardiac recovery, as revealed by echocardiography.
Seven patients (group A) had recurrent cardiac failure after 4 to 24 months. Transplantation was performed in 6 patients, and one died while on the waiting list. Three patients died of noncardiac causes within a period of 4 months and 3 days after removal of the assist device. Stable cardiac recovery occurred in 13 patients (group B) for 3 to 49 months (mean, 23 months). At the time of implantation, there were no significant differences between the groups with regard to age, hemodynamics, left ventricular ejection fraction, left ventricular internal diameter in diastole, and autoantibody levels. The increase of ejection fraction and the decrease of left ventricular internal diameter in diastole after 2 months were highly significant. The patients in group A had longer histories of heart failure and first cardiac symptoms and duration of assist when compared with group B. Group B demonstrated a quicker cardiac recovery on the assist device, and thus support was shorter. Also, the degree of recovery at assist device explantation was more complete in group B. The age at the time of device placement was the only influencing factor for duration on the assist device. The probability of recurrence of heart failure was influenced by the duration of heart failure.
In selected patients with idiopathic dilated cardiomyopathy, lasting recovery can be achieved after unloading with a left ventricular assist device. Lasting cardiac recovery seems to be related to functional normalization and a more rapid recovery during the unloading period.
终末期特发性扩张型心肌病患者在接受左心室辅助装置临时支持后近期出现心脏恢复情况。我们报告了4年多前接受该装置移除手术的患者的病例史。
自1994年6月起,23例终末期特发性扩张型心肌病患者接受了左心室辅助装置或双心室辅助装置支持1至26个月(平均6个月),经超声心动图显示心脏完全或广泛恢复后接受了装置移除手术。
7例患者(A组)在4至24个月后出现复发性心力衰竭。6例患者接受了移植手术,1例在等待移植期间死亡。3例患者在移除辅助装置后4个月零3天内死于非心脏原因。13例患者(B组)实现了稳定的心脏恢复,持续3至49个月(平均23个月)。植入时,两组在年龄、血流动力学、左心室射血分数、舒张期左心室内径和自身抗体水平方面无显著差异。2个月后射血分数增加和舒张期左心室内径减小非常显著。与B组相比,A组患者的心力衰竭病史、首次心脏症状和辅助支持时间更长。B组在辅助装置上心脏恢复更快,因此支持时间更短。此外,B组在辅助装置移除时的恢复程度更完全。装置放置时的年龄是辅助装置使用时间的唯一影响因素。心力衰竭复发的可能性受心力衰竭持续时间的影响。
在选定的特发性扩张型心肌病患者中,使用左心室辅助装置卸载后可实现持久恢复。持久的心脏恢复似乎与功能正常化以及卸载期间更快的恢复有关。